Skip to main content
T

TaiDoc Technology Corporation — Investor Relations & Filings

Ticker · 4736 TW Manufacturing
Open in API
Filings indexed 1,685 across all filing types
Latest filing 2026-04-28 Report Publication Anno…
Country TW Taiwan
Listing TW 4736

About TaiDoc Technology Corporation

http://www.taidoc.com.tw

TaiDoc Technology Corporation is a professional medical device manufacturer specializing in the development and production of diagnostic and monitoring solutions. The company integrates biochemical technology, medical electronics, and optical engineering to serve four primary sectors: home care, clinical environments, diagnostic analysis, and telemedicine. Its diverse product portfolio includes blood glucose monitoring systems, blood pressure monitors, ear thermometers, pulse oximeters, COVID-19 antigen rapid test kits, nebulizers, and ECG machines. Many devices feature IoT connectivity, enabling integration with proprietary software for remote health management. TaiDoc maintains a comprehensive internal workflow encompassing industrial design, software development, and product certification. With a consistent investment of over 6% of annual revenue in R&D, the company focuses on technological innovation to deliver precision medical instruments.

Recent filings

Filing Released Lang Actions
公告本公司115年第一季合併財務報告董事會召開日期
Report Publication Announcement Classification · 1% confidence The document is a Taiwan Market Observation Post System (公開資訊觀測站) announcement by company 4736 泰博 stating the date the board will convene to approve the Q1 consolidated financial report. It does not contain the report itself but announces the timing of the report’s board approval/publication. This matches the definition of a Report Publication Announcement (RPA).
2026-04-28 Chinese
115年年報及股東會資料 — 2026_4736_20260527FE2.pdf
Regulatory Filings
2026-04-24 Chinese
115年年報及股東會資料 — 2026_4736_20260527F13.pdf
AGM Information Classification · 1% confidence The document is a set of reference materials for the company’s 115th Annual General Meeting proposals, including approval of the 114th financial statements, earnings distribution, and discussion of capital surplus conversion to new shares. It is clearly material provided for an AGM rather than the full annual report or just an announcement. Hence it is classified as AGM Information (AGM-R).
2026-04-24 Chinese
115年年報及股東會資料 — 2026_4736_20260527F02.pdf
Regulatory Filings
2026-04-24 Chinese
115年年報及股東會資料 — 2026_4736_20260527FE1.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of the 2026 annual shareholders’ meeting, including the meeting agenda, proposals to be voted on, proxy form instructions, and voting procedures. It is sent to shareholders to provide information about the meeting and solicit their votes (including proxy voting and electronic voting details). This matches the definition of a Proxy Solicitation & Information Statement (PSI) rather than an AGM presentation (AGM-R) or a simple report announcement (RPA).
2026-04-24 English
115年年報及股東會資料 — 2026_4736_20260527F01.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder meeting notice (“開會通知書”) including the proxy form (“委託書”), dividend election form and other AGM materials sent to shareholders to provide information on meeting agenda items and request voting proxies. This is not the actual AGM presentation deck but the solicitation/information statement for the Annual General Meeting. Therefore, it falls under Proxy Solicitation & Information Statement (PSI).
2026-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.